Lanthanide‐Doped LiLuF4 Upconversion Nanoprobes for the Detection of Disease Biomarkers

Lanthanide-doped upconversion nanoparticles (UCNPs) have shown great promise in bioapplications. Exploring new host materials to realize efficient upconversion luminescence (UCL) output is a goal of general concern. Herein, we develop a unique strategy for the synthesis of novel LiLuF4 :Ln(3+) core/shell UCNPs with typically high absolute upconversion quantum yields of 5.0 % and 7.6 % for Er(3+) and Tm(3+) , respectively. Based on our customized UCL biodetection system, we demonstrate for the first time the application of LiLuF4 :Ln(3+) core/shell UCNPs as sensitive UCL bioprobes for the detection of an important disease marker β subunit of human chorionic gonadotropin (β-hCG) with a detection limit of 3.8 ng mL(-1) , which is comparable to the β-hCG level in the serum of normal humans. Furthermore, we use these UCNPs in proof-of-concept computed tomography imaging and UCL imaging of cancer cells, thus revealing the great potential of LiLuF4 :Ln(3+) UCNPs as efficient nano-bioprobes in disease diagnosis.